Transcription of Clinical manifestations, risk factors, and maternal and ...
{{id}} {{{paragraph}}}
Example: stock market
Clinical manifestations, risk factors, and maternal and ...
The bmj | BMJ 2020;370:m3320 | doi: 1 RESEARCHC linical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisJohn Allotey,1,2 Elena Stallings,3,4 Mercedes Bonet,5 Magnus Yap,6 Shaunak Chatterjee,6 Tania Kew,6 Luke Debenham,6 Anna Clav Llavall,6 Anushka Dixit,6 Dengyi Zhou,6 Rishab Balaji,6 Siang Ing Lee,1 Xiu Qiu,7,8,9 Mingyang Yuan,1,7 Dyuti Coomar,1 Jameela Sheikh,6 Heidi Lawson,6 Kehkashan Ansari,2 Madelon van Wely,10 Elizabeth van Leeuwen,11 Elena Kostova,10 Heinke Kunst,12,13 Asma Khalil,14 Simon Tiberi,12,13 Vanessa Brizuela,5 Nathalie Broutet,5 Edna Kara,3 Caron Rahn Kim,5 Anna Thorson,5 Ram n Escuriet,15 Olufemi T Oladapo,5 Lynne Mofenson,16 Javier Zamora,2,3,4 Shakila Thangaratinam,2,18 on behalf of the PregCOV-19 Living systematic review ConsortiumAbstrActObjectiveTo determine the Clinical manifestations, risk factors.
Sep 01, 2020 · the preferred reporting items for systematic reviews and meta-analyses (PRISMA) recommendations (see appendix 1). As more relevant data become availa-ble, we shall address the research questions in our published protocol.20 Each cycle of our living systematic review involves weekly search updates (rounds), with analysis performed every 2-4 months
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: